DaVita (DVA)
(Delayed Data from NYSE)
$138.48 USD
-1.89 (-1.35%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $138.46 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, DaVita Inc. has a market cap of $10.60B, which represents its share price of $140.37 multiplied by its outstanding shares number of 75.50M. As a large-cap company, DVA's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
DVA 138.48 -1.89(-1.35%)
Will DVA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVA
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
DVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemed (CHE) Q2 Earnings Miss Estimates
DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings Growth
Universal Health to Report Q2 Earnings: What Do the Key Estimates Say?
Other News for DVA
DaVita Inc (DVA) Partners with Food is Medicine Coalition to Address Chronic Illness and Food ...
Insider Sell Alert: James Hearty Sells Shares of DaVita Inc (DVA)
DaVita Breaks Above 200-Day Moving Average - Bullish for DVA
Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)
DaVita Inc (DVA) Announces Second Quarter 2025 Investor Conference Call | DVA stock news